Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study

Cord blood transplantation (CBT) is an effective option for treating hematological malignancies, but graft failure (GF) remains the primary cause of therapy failure. Thus, based on myeloablative conditioning (MAC) of busulfan with cyclophosphamide (Bu/Cy) or total body irradiation with Cy (TBI/Cy),...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Zimin, Liu, Huilan, Luo, Chenhui, Geng, Liangquan, Zheng, Changcheng, Tang, Baolin, Zhu, Xiaoyu, Tong, Juan, Wang, Xingbing, Ding, Kaiyang, Wan, Xiang, Zhang, Lei, Yao, Wen, Song, Kaiding, Zhang, Xuhan, Wu, Yue, Yang, Huizhi, Han, Yongsheng, Liu, Xin, Zhu, Weibo, Wu, Jingsheng, Wang, Zuyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Cancer Therapy and Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033117/
https://www.ncbi.nlm.nih.gov/pubmed/29473150
http://dx.doi.org/10.1002/ijc.31339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033117/
https://www.ncbi.nlm.nih.gov/pubmed/29473150
http://dx.doi.org/10.1002/ijc.31339

Ejemplares similares